{"id": "uFrilFcAAAAJ", "citedby": 3378, "citedby5y": 2719, "hindex": 16, "hindex5y": 15, "i10index": 19, "i10index5y": 16, "coauthors": [], "name": "Iris Romero", "affiliation": "University of Chciago", "interests": ["ovarian cancer", "hereditary breast and ovarian cancer"], "cites_per_year": {"2010": 14, "2011": 63, "2012": 111, "2013": 184, "2014": 250, "2015": 291, "2016": 447, "2017": 516, "2018": 563, "2019": 600, "2020": 296}, "publications": [{"bib": {"title": "Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth", "year": "2011"}, "source": "citations", "id_citations": "uFrilFcAAAAJ:d1gkVwhDpl0C", "citedby": "1196"}, {"bib": {"title": "Adipose tissue and adipocytes support tumorigenesis and metastasis", "year": "2013"}, "source": "citations", "id_citations": "uFrilFcAAAAJ:eQOLeE2rZwMC", "citedby": "456"}, {"bib": {"title": "Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer", "year": "2015"}, "source": "citations", "id_citations": "uFrilFcAAAAJ:Tyk-4Ss8FVUC", "citedby": "449"}, {"bib": {"title": "CD95 promotes tumour growth", "year": "2010"}, "source": "citations", "id_citations": "uFrilFcAAAAJ:u-x6o8ySG0sC", "citedby": "361"}, {"bib": {"title": "Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion", "year": "2014"}, "source": "citations", "id_citations": "uFrilFcAAAAJ:Y0pCki6q_DkC", "citedby": "155"}, {"bib": {"title": "Relationship of type II diabetes and metformin use to ovarian cancer progression, survival, and chemosensitivity", "year": "2012"}, "source": "citations", "id_citations": "uFrilFcAAAAJ:zYLM7Y9cAGgC", "citedby": "145"}, {"bib": {"title": "Foretinib (GSK1363089), an orally available multikinase inhibitor of c-Met and VEGFR-2, blocks proliferation, induces anoikis, and impairs ovarian cancer metastasis", "year": "2011"}, "source": "citations", "id_citations": "uFrilFcAAAAJ:WF5omc3nYNoC", "citedby": "108"}, {"bib": {"title": "Metformin targets central carbon metabolism and reveals mitochondrial requirements in human cancers", "year": "2016"}, "source": "citations", "id_citations": "uFrilFcAAAAJ:YsMSGLbcyi4C", "citedby": "105"}, {"bib": {"title": "Metformin inhibits ovarian cancer growth and increases sensitivity to paclitaxel in mouse models", "year": "2015"}, "source": "citations", "id_citations": "uFrilFcAAAAJ:qjMakFHDy7sC", "citedby": "84"}, {"bib": {"title": "Molecular pathways: trafficking of metabolic resources in the tumor microenvironment", "year": "2015"}, "source": "citations", "id_citations": "uFrilFcAAAAJ:ufrVoPGSRksC", "citedby": "59"}, {"bib": {"title": "Old drug, new trick: repurposing metformin for gynecologic cancers?", "year": "2014"}, "source": "citations", "id_citations": "uFrilFcAAAAJ:9yKSN-GCB0IC", "citedby": "55"}, {"bib": {"title": "Statin therapy is associated with improved survival in patients with non-serous-papillary epithelial ovarian cancer: a retrospective cohort analysis", "year": "2014"}, "source": "citations", "id_citations": "uFrilFcAAAAJ:2osOgNQ5qMEC", "citedby": "38"}, {"bib": {"title": "Association of metformin use with outcomes in advanced endometrial cancer treated with chemotherapy", "year": "2016"}, "source": "citations", "id_citations": "uFrilFcAAAAJ:u5HHmVD_uO8C", "citedby": "31"}, {"bib": {"title": "Hyperglycemia-induced metabolic compensation inhibits metformin sensitivity in ovarian cancer", "year": "2015"}, "source": "citations", "id_citations": "uFrilFcAAAAJ:UeHWp8X0CEIC", "citedby": "27"}, {"bib": {"title": "A randomized trial of tramadol versus ibuprofen as an adjunct to pain control during vacuum aspiration abortion", "year": "2008"}, "source": "citations", "id_citations": "uFrilFcAAAAJ:_FxGoFyzp5QC", "citedby": "20"}, {"bib": {"title": "Effects of oral contraceptives or a gonadotropin-releasing hormone agonist on ovarian carcinogenesis in genetically engineered mice", "year": "2009"}, "source": "citations", "id_citations": "uFrilFcAAAAJ:IjCSPb-OGe4C", "citedby": "19"}, {"bib": {"title": "A Pan-ALDH1A inhibitor induces necroptosis in ovarian cancer stem-like cells", "year": "2019"}, "source": "citations", "id_citations": "uFrilFcAAAAJ:iH-uZ7U-co4C", "citedby": "16"}, {"bib": {"title": "Intensive surveillance with biannual dynamic contrast-enhanced magnetic resonance imaging downstages breast cancer in BRCA1 mutation carriers", "year": "2019"}, "source": "citations", "id_citations": "uFrilFcAAAAJ:qUcmZB5y_30C", "citedby": "11"}, {"bib": {"title": "The effects of 17\u03b2-estradiol and a selective estrogen receptor modulator, bazedoxifene, on ovarian carcinogenesis", "year": "2012"}, "source": "citations", "id_citations": "uFrilFcAAAAJ:W7OEmFMy1HYC", "citedby": "10"}, {"bib": {"title": "Genetic Testing and Clinical Management Practices for Variants in Non-BRCA1/2 Breast (and Breast/Ovarian) Cancer Susceptibility Genes: An International \u2026", "year": "2018"}, "source": "citations", "id_citations": "uFrilFcAAAAJ:hFOr9nPyWt4C", "citedby": "7"}, {"bib": {"title": "Loss of BRCA1 in the cells of origin of ovarian cancer induces glycolysis: a window of opportunity for ovarian cancer chemoprevention", "year": "2017"}, "source": "citations", "id_citations": "uFrilFcAAAAJ:LkGwnXOMwfcC", "citedby": "7"}, {"bib": {"title": "SPHK1 is a novel target of metformin in ovarian cancer", "year": "2019"}, "source": "citations", "id_citations": "uFrilFcAAAAJ:TQgYirikUcIC", "citedby": "4"}, {"bib": {"title": "Genetic testing and clinical management practices for variants in non-BRCA1/2 breast (and/or ovarian) cancer susceptibility genes: An international survey by the \u2026", "year": "2018"}, "source": "citations", "id_citations": "uFrilFcAAAAJ:9ZlFYXVOiuMC", "citedby": "3"}, {"bib": {"title": "Lesbian pregnancy: care and considerations", "year": "2017"}, "source": "citations", "id_citations": "uFrilFcAAAAJ:Se3iqnhoufwC", "citedby": "3"}, {"bib": {"title": "WISP: A prospective, multi-center trial of salpingectomy with delayed oophorectomy versus risk reducing salpingo-oophorectomy in women at increased risk for hereditary ovarian \u2026", "year": "2019"}, "source": "citations", "id_citations": "uFrilFcAAAAJ:maZDTaKrznsC", "citedby": "2"}, {"bib": {"title": "Mesothelial Cell HIF1\u03b1 Expression Is Metabolically Downregulated by Metformin to Prevent Oncogenic Tumor-Stromal Crosstalk", "year": "2019"}, "source": "citations", "id_citations": "uFrilFcAAAAJ:M3NEmzRMIkIC", "citedby": "1"}, {"bib": {"title": "MAGENTA (Making Genetic testing accessible): a prospective randomized controlled trial comparing online genetic education and telephone genetic counseling for hereditary cancer \u2026", "year": "2019"}, "source": "citations", "id_citations": "uFrilFcAAAAJ:k_IJM867U9cC", "citedby": "1"}, {"bib": {"title": "Obstetrics and gynecology: A specialty at the forefront of care for LGBTQ patients", "year": "2017"}, "source": "citations", "id_citations": "uFrilFcAAAAJ:roLk4NBRz8UC", "citedby": "1"}, {"bib": {"title": "Metformin inhibits TGF\u03b2-induced stromal ECM remodeling to impede invasion in ovarian cancer", "year": "2017"}, "source": "citations", "id_citations": "uFrilFcAAAAJ:8k81kl-MbHgC", "citedby": "1"}, {"bib": {"title": "Advancing metformin as a metabolic therapeutic for ovarian cancer: testing in non-diabetic patient-derived xenograft avatars", "year": "2015"}, "source": "citations", "id_citations": "uFrilFcAAAAJ:Zph67rFs4hoC", "citedby": "1"}, {"bib": {"title": "Hyperglycemia inhibits the anti-cancer effects of metformin", "year": "2014"}, "source": "citations", "id_citations": "uFrilFcAAAAJ:M3ejUd6NZC8C", "citedby": "1"}, {"bib": {"title": "Effects of oral contraceptives or a gonadotropin-releasing hormone agonist on ovarian carcinogenesis in genetically engineered mice", "year": "2010"}, "source": "citations", "id_citations": "uFrilFcAAAAJ:3fE2CSJIrl8C", "citedby": "1"}, {"bib": {"title": "Adipocyte-induced FABP4 expression in ovarian cancer cells promotes metastasis and mediates carboplatin resistance", "year": "2020"}, "source": "citations", "id_citations": "uFrilFcAAAAJ:NMxIlDl6LWMC", "citedby": "0"}, {"bib": {"title": "Germline genetic testing in ovarian cancer patients: Identifying barriers to care and opportunities for improvement.", "year": "2019"}, "source": "citations", "id_citations": "uFrilFcAAAAJ:TFP_iSt0sucC", "citedby": "0"}, {"bib": {"title": "Stromal regulation of metastasis.", "year": "2018"}, "source": "citations", "id_citations": "uFrilFcAAAAJ:hC7cP41nSMkC", "citedby": "0"}, {"bib": {"title": "Abstract IA06: Stromal regulation of metastasis", "year": "2018"}, "source": "citations", "id_citations": "uFrilFcAAAAJ:IWHjjKOFINEC", "citedby": "0"}, {"bib": {"title": "Abstract A15: Fatty acid binding protein 4 is indispensable for ovarian cancer metastasis", "year": "2018"}, "source": "citations", "id_citations": "uFrilFcAAAAJ:ZeXyd9-uunAC", "citedby": "0"}, {"bib": {"title": "Activity of the S1P pathway promotes ovarian cancer and serves as a novel metabolic target of metformin", "year": "2018"}, "source": "citations", "id_citations": "uFrilFcAAAAJ:L8Ckcad2t8MC", "citedby": "0"}, {"bib": {"title": "Diverse indications for risk-reducing salpingo-oophorectomy: Experience from a tertiary care center", "year": "2018"}, "source": "citations", "id_citations": "uFrilFcAAAAJ:7PzlFSSx8tAC", "citedby": "0"}, {"bib": {"title": "Abstract P5-19-04: Psychosocial impact of a multi-modality surveillance program for women at high-risk for breast cancer", "year": "2018"}, "source": "citations", "id_citations": "uFrilFcAAAAJ:4DMP91E08xMC", "citedby": "0"}, {"bib": {"title": "Fatty acid binding protein 4 is indispensable for ovarian cancer metastasis.", "year": "2018"}, "source": "citations", "id_citations": "uFrilFcAAAAJ:-f6ydRqryjwC", "citedby": "0"}, {"bib": {"title": "Abstract A68: Sphingosine kinase 1 as a mediator and predictor of metformin's protective effect in ovarian cancer.", "year": "2016"}, "source": "citations", "id_citations": "uFrilFcAAAAJ:YOwf2qJgpHMC", "citedby": "0"}, {"bib": {"title": "BAP1 Expression Is Preserved in BRCA-Associated Serous Carcinoma of the Ovary", "year": "2016"}, "source": "citations", "id_citations": "uFrilFcAAAAJ:Wp0gIr-vW9MC", "citedby": "0"}, {"bib": {"title": "Metformin acts to disrupt mitochondrial-associated metabolic homeostasis in human cancer", "year": "2015"}, "source": "citations", "id_citations": "uFrilFcAAAAJ:dhFuZR0502QC", "citedby": "0"}, {"bib": {"title": "Advancing metformin as therapeutic for ovarian cancer: metabolomic profiling of mouse ovarian tumors identifies metformin-induced global metabolic changes", "year": "2015"}, "source": "citations", "id_citations": "uFrilFcAAAAJ:aqlVkmm33-oC", "citedby": "0"}, {"bib": {"title": "Abstract POSTER-TECH-1123: Advancing metformin as therapeutic for ovarian cancer: metabolomic profiling of mouse ovarian tumors identifies metformin-induced global metabolic \u2026", "year": "2015"}, "source": "citations", "id_citations": "uFrilFcAAAAJ:ULOm3_A8WrAC", "citedby": "0"}, {"bib": {"title": "Abstract POSTER-BIOL-1305: Lovastatin decreases macrophage IL-6 and CXCL1 production in an ovarian tam-like model reducing ovarian cancer cell invasion", "year": "2015"}, "source": "citations", "id_citations": "uFrilFcAAAAJ:kNdYIx-mwKoC", "citedby": "0"}, {"bib": {"title": "Lovastatin decreases macrophage IL-6 and CXCL1 production in an ovarian tam-like model reducing ovarian cancer cell invasion", "year": "2015"}, "source": "citations", "id_citations": "uFrilFcAAAAJ:MXK_kJrjxJIC", "citedby": "0"}, {"bib": {"title": "A retrospective analysis of the relationship between diabetes, metformin use, and survival in advanced endometrial cancer patients treated with chemotherapy.", "year": "2014"}, "source": "citations", "id_citations": "uFrilFcAAAAJ:KlAtU1dfN6UC", "citedby": "0"}, {"bib": {"title": "CD95 promotes tumour growth (vol 465, pg 492, 2010)", "year": "2012"}, "source": "citations", "id_citations": "uFrilFcAAAAJ:e5wmG9Sq2KIC", "citedby": "0"}, {"bib": {"title": "Corrigendum: CD95 promotes tumour growth", "year": "2012"}, "source": "citations", "id_citations": "uFrilFcAAAAJ:4JMBOYKVnBMC", "citedby": "0"}, {"bib": {"title": "Lovastatin decreases ovarian cancer cell proliferation and invasion: A case for statin therapy for ovarian cancer patients?", "year": "2012"}, "source": "citations", "id_citations": "uFrilFcAAAAJ:UebtZRa9Y70C", "citedby": "0"}, {"bib": {"title": "Metformin: A novel agent for ovarian cancer prevention and adjuvant treatment", "year": "2012"}, "source": "citations", "id_citations": "uFrilFcAAAAJ:5nxA0vEk-isC", "citedby": "0"}, {"bib": {"title": "Relationship of Type II Diabetes and Metformin Use to Ovarian Cancer Progression, Survival, and Chemosensitivity EDITORIAL COMMENT", "year": "2012"}, "source": "citations", "id_citations": "uFrilFcAAAAJ:RHpTSmoSYBkC", "citedby": "0"}, {"bib": {"title": "Erratum: CD95 promotes tumour growth (Nature (2011) 471 (254", "year": "2011"}, "source": "citations", "id_citations": "uFrilFcAAAAJ:j3f4tGmQtD8C", "citedby": "0"}, {"bib": {"title": "CD95 promotes tumour growth", "year": "2011"}, "source": "citations", "id_citations": "uFrilFcAAAAJ:JV2RwH3_ST0C", "citedby": "0"}, {"bib": {"title": "Erratum: CD95 promotes tumour growth", "year": "2011"}, "source": "citations", "id_citations": "uFrilFcAAAAJ:blknAaTinKkC", "citedby": "0"}, {"bib": {"title": "Metformin Inhibits Growth and Invasion of Ovarian cancer; An Effect That Maybe Mediated By AMP-Activated Kinase", "year": "2011"}, "source": "citations", "id_citations": "uFrilFcAAAAJ:QIV2ME_5wuYC", "citedby": "0"}, {"bib": {"title": "Abstract A103: The effect of 17\u03b2-estradiol on ovarian carcinogenesis in vitro and in a genetic mouse model", "year": "2010"}, "source": "citations", "id_citations": "uFrilFcAAAAJ:4TOpqqG69KYC", "citedby": "0"}, {"bib": {"title": "Abstract LB-341: CD95/FAS promotes tumorigenesis", "year": "2010"}, "source": "citations", "id_citations": "uFrilFcAAAAJ:hqOjcs7Dif8C", "citedby": "0"}, {"bib": {"title": "RUNX3 targets estrogen receptor a for proteasome-mediated degradation suppressing breast cancer tumorigenesis", "year": "2010"}, "source": "citations", "id_citations": "uFrilFcAAAAJ:isC4tDSrTZIC", "citedby": "0"}, {"bib": {"title": "Metformin Inhibits Growth and Invasion in Several Ovarian Cancer Cell Lines; an Effect That May Be Mediated by Activation of AMP-Activated Kinase", "year": "2010"}, "source": "citations", "id_citations": "uFrilFcAAAAJ:_kc_bZDykSQC", "citedby": "0"}, {"bib": {"title": "The evaluation of norethindrone, ethinyl estradiol and a GnRh agonist as chemoprevention of ovarian cancer using a newly developed genetically engineered mouse model of ovarian \u2026", "year": "2007"}, "source": "citations", "id_citations": "uFrilFcAAAAJ:0EnyYjriUFMC", "citedby": "0"}, {"bib": {"title": "CD95/Fas promotes tumour growth"}, "source": "citations", "id_citations": "uFrilFcAAAAJ:r0BpntZqJG4C", "citedby": "0"}, {"bib": {"title": "Outcome Measures"}, "source": "citations", "id_citations": "uFrilFcAAAAJ:_Qo2XoVZTnwC", "citedby": "0"}, {"bib": {"title": "Intensive surveillance with bi-annual dynamic contrast-enhanced magnetic resonance imaging downstages breast cancer in BRCA1 mutation carriers"}, "source": "citations", "id_citations": "uFrilFcAAAAJ:HDshCWvjkbEC", "citedby": "0"}, {"bib": {"title": "400-\u00b5g Vaginal Misoprostol and Systematic Curettage Postexpulsion: A Randomized Trial JL Carbonell, MA Torres, R. Reyes, L. Ortega"}, "source": "citations", "id_citations": "uFrilFcAAAAJ:qxL8FJ1GzNcC", "citedby": "0"}]}